{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T11:16:31Z","timestamp":1762341391505,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T00:00:00Z","timestamp":1577923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T00:00:00Z","timestamp":1577923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2020,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Prolonged life expectancies contribute to the increasing prevalence of age-related macular degeneration (AMD) that is already the leading cause of severe vision loss among the elderly in developed countries. In dry AMD, the disease culminates into vast retinal atrophy, whereas the wet form is characterized by retinal edema and sudden vision loss due to neovascularization originating from the choroid beneath the Bruch\u2019s membrane. There is no treatment for dry AMD and despite intravitreal injections of anti-vascular endothelial growth factor (VEGF) that suppress the neovessel formation, also wet AMD needs new therapies to prevent the disease progression and to serve patients lacking of positive response to current medicines. Knowledge on disease mechanisms is a prerequisite for the drug development, which is hindered by the multifactorial nature of AMD. Numerous distinguished publications have revealed AMD mechanisms at the cellular and molecular level and in this multi-author review, we take a bit broader look at the topic with some novel aspects.<\/jats:p>","DOI":"10.1007\/s00018-019-03418-5","type":"journal-article","created":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T07:02:53Z","timestamp":1577948573000},"page":"779-780","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Introduction to the multi-author review on macular degeneration"],"prefix":"10.1007","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8254-0200","authenticated-orcid":false,"given":"Anu","family":"Kauppinen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,2]]},"reference":[{"key":"3418_CR1","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201708259","author":"I Akhtar-Schafer","year":"2018","unstructured":"Akhtar-Schafer I, Wang L, Krohne TU, Xu H, Langmann T (2018) Modulation of three key innate immune pathways for the most common retinal degenerative diseases. EMBO Mol Med. https:\/\/doi.org\/10.15252\/emmm.201708259","journal-title":"EMBO Mol Med"},{"key":"3418_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19123846","author":"E Alizadeh","year":"2018","unstructured":"Alizadeh E, Mammadzada P, Andre H (2018) The different facades of retinal and choroidal endothelial cells in response to hypoxia. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms19123846","journal-title":"Int J Mol Sci"},{"key":"3418_CR3","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/nri3459","volume":"13","author":"J Ambati","year":"2013","unstructured":"Ambati J, Atkinson JP, Gelfand BD (2013) Immunology of age-related macular degeneration. Nat Rev Immunol 13:438\u2013451","journal-title":"Nat Rev Immunol"},{"key":"3418_CR4","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.preteyeres.2013.07.003","volume":"37","author":"D Ardeljan","year":"2013","unstructured":"Ardeljan D, Chan CC (2013) Aging is not a disease: distinguishing age-related macular degeneration from aging. Prog Retin Eye Res 37:68\u201369","journal-title":"Prog Retin Eye Res"},{"key":"3418_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1471-2415-10-31","volume":"10","author":"U Chakravarthy","year":"2010","unstructured":"Chakravarthy U, Wong TY, Fletcher A, Piault E, Evans C, Zlateva G, Buggage R, Pleil A, Mitchell P (2010) Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol 10:31","journal-title":"BMC Ophthalmol"},{"key":"3418_CR6","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.preteyeres.2018.10.003","volume":"69","author":"M Chen","year":"2019","unstructured":"Chen M, Luo C, Zhao J, Devarajan G, Xu H (2019) Immune regulation in the aging retina. Prog Retin Eye Res 69:159\u2013172","journal-title":"Prog Retin Eye Res"},{"key":"3418_CR7","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1038\/nm.4000","volume":"21","author":"BG Childs","year":"2015","unstructured":"Childs BG, Durik M, Baker DJ, van Deursen JM (2015) Cellular senescence in aging and age-related disease: from mechanisms to therapy. Nat Med 21:1424\u20131435","journal-title":"Nat Med"},{"key":"3418_CR8","doi-asserted-by":"publisher","first-page":"AMD83","DOI":"10.1167\/iovs.18-23893","volume":"59","author":"DA Copland","year":"2018","unstructured":"Copland DA, Theodoropoulou S, Liu J, Dick AD (2018) A perspective of AMD through the eyes of immunology. Investig Ophthalmol Vis Sci 59:AMD83\u2013AMD92","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"3418_CR9","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.preteyeres.2015.09.002","volume":"51","author":"DA Ferrington","year":"2016","unstructured":"Ferrington DA, Sinha D, Kaarniranta K (2016) Defects in retinal pigment epithelial cell proteolysis and the pathology associated with age-related macular degeneration. Prog Retin Eye Res 51:69\u201389","journal-title":"Prog Retin Eye Res"},{"key":"3418_CR10","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1007\/s00018-016-2147-8","volume":"73","author":"A Kauppinen","year":"2016","unstructured":"Kauppinen A, Paterno JJ, Blasiak J, Salminen A, Kaarniranta K (2016) Inflammation and its role in age-related macular degeneration. Cell Mol Life Sci 73:1765\u20131786","journal-title":"Cell Mol Life Sci"},{"key":"3418_CR11","first-page":"1","volume-title":"Handbook of immunosenescence: basic understanding and clinical implications","author":"A Kauppinen","year":"2017","unstructured":"Kauppinen A (2017) Mitochondria-associated inflammasome activation and its impact on aging and age-related diseases. In: Fulop T, Franceschi C, Hirokawa K, Pawelec G (eds) Handbook of immunosenescence: basic understanding and clinical implications. Springer International Publishing, Cham, pp 1\u201320"},{"key":"3418_CR12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.mito.2017.03.006","volume":"36","author":"E Lefevere","year":"2017","unstructured":"Lefevere E, Toft-Kehler AK, Vohra R, Kolko M, Moons L, Van Hove I (2017) Mitochondrial dysfunction underlying outer retinal diseases. Mitochondrion 36:66\u201376","journal-title":"Mitochondrion"},{"key":"3418_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.13332","author":"D Li","year":"2019","unstructured":"Li D, Yan Sun W, Fu B, Xu A, Wang Y (2019) Lipocalin-2\u2014the myth of its expression and function. Basic Clin Pharmacol Toxicol. https:\/\/doi.org\/10.1111\/bcpt.13332","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"3418_CR14","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/S0140-6736(12)60282-7","volume":"379","author":"LS Lim","year":"2012","unstructured":"Lim LS, Mitchell P, Seddon JM, Holz FG, Wong TY (2012) Age-related macular degeneration. Lancet 379:1728\u20131738","journal-title":"Lancet"},{"key":"3418_CR15","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.optom.2013.07.002","volume":"6","author":"M Mousavi","year":"2013","unstructured":"Mousavi M, Armstrong RA (2013) Genetic risk factors and age-related macular degeneration (AMD). J Optom 6:176\u2013184","journal-title":"J Optom"},{"key":"3418_CR16","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1007\/s00018-012-0962-0","volume":"69","author":"A Salminen","year":"2012","unstructured":"Salminen A, Ojala J, Kaarniranta K, Kauppinen A (2012) Mitochondrial dysfunction and oxidative stress activate inflammasomes: impact on the aging process and age-related diseases. Cell Mol Life Sci 69:2999\u20133013","journal-title":"Cell Mol Life Sci"},{"key":"3418_CR17","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0002-9394(14)71036-0","volume":"123","author":"JM Seddon","year":"1997","unstructured":"Seddon JM, Ajani UA, Mitchell BD (1997) Familial aggregation of age-related maculopathy. Am J Ophthalmol 123:199\u2013206","journal-title":"Am J Ophthalmol"},{"key":"3418_CR18","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.preteyeres.2010.09.003","volume":"30","author":"E Stefansson","year":"2011","unstructured":"Stefansson E, Geirsdottir A, Sigurdsson H (2011) Metabolic physiology in age related macular degeneration. Prog Retin Eye Res 30:72\u201380","journal-title":"Prog Retin Eye Res"},{"key":"3418_CR19","doi-asserted-by":"publisher","first-page":"5783","DOI":"10.1167\/iovs.09-5098","volume":"51","author":"S Sugita","year":"2010","unstructured":"Sugita S, Horie S, Yamada Y, Mochizuki M (2010) Inhibition of B-cell activation by retinal pigment epithelium. Investig Ophthalmol Vis Sci 51:5783\u20135788","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"3418_CR20","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/eye.2017.245","volume":"32","author":"A Warwick","year":"2018","unstructured":"Warwick A, Lotery A (2018) Genetics and genetic testing for age-related macular degeneration. Eye (Lond) 32:849\u2013857","journal-title":"Eye (Lond)"},{"key":"3418_CR21","first-page":"A160","volume":"114","author":"B Weinhold","year":"2006","unstructured":"Weinhold B (2006) Epigenetics: the science of change. Environ Health Perspect 114:A160\u2013A167","journal-title":"Environ Health Perspect"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-019-03418-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00018-019-03418-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-019-03418-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T01:31:59Z","timestamp":1609464719000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00018-019-03418-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,2]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["3418"],"URL":"https:\/\/doi.org\/10.1007\/s00018-019-03418-5","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"type":"print","value":"1420-682X"},{"type":"electronic","value":"1420-9071"}],"subject":[],"published":{"date-parts":[[2020,1,2]]},"assertion":[{"value":"4 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}